Trial of Montelukast in Eosinophilic Esophagitis
Condition: Eosinophilic EsophagitisInterventions: Drug: Montelukast/ Singulair; Drug: PlaceboSponsors: Mayo Clinic; Merck Sharp & Dohme Corp.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2007 Category: Research Source Type: clinical trials
Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)
Condition: AsthmaInterventions: Drug: MK0476, montelukast sodium / Duration of Treatment: 4 Weeks; Drug: Comparator: ketotifen / Duration of Treatment: 4 WeeksSponsor: Merck Sharp & Dohme Corp.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2007 Category: Research Source Type: clinical trials
SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)
Condition: AsthmaIntervention: Drug: MK0476, montelukast sodium / Duration of Treatment: 8 WeeksSponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2007 Category: Research Source Type: clinical trials
To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)
Condition: AsthmaIntervention: Drug: MK0476, montelukast sodium / Duration of Treatment: 12 WeeksSponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2006 Category: Research Source Type: clinical trials
Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
Conditions: Asthma; Rhinitis AllergicIntervention: Drug: MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 WeeksSponsor: Merck Sharp & Dohme Corp.Completed - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2006 Category: Research Source Type: clinical trials
